Related by context. All words. (Click for frequent words.) 70 mertansine 69 GRN# 69 proteasome inhibitor 68 Sym# 68 LT NS# 67 AEG# 67 cannabinor 67 investigational humanized monoclonal antibody 67 XmAb# 67 pan HDAC inhibitor 67 Xanafide 67 CYT# potent vascular disrupting 67 orally bioavailable 67 HQK 67 Archexin 67 huC# DM4 66 Symadex 66 Factor VIIa 66 JAK inhibitor 66 vascular disrupting agents 66 oral prodrug 66 taxane derivative 66 Carfilzomib 66 targeted radiotherapeutic 66 Tyrima 66 isoform selective 66 INCB# [001] 66 ESBA# 66 metaglidasen 65 chimeric monoclonal antibody 65 anti amnesic 65 novel VDA molecule 65 receptor tyrosine kinase inhibitor 65 therapeutic monoclonal antibody 65 IMA# 65 Hsp# Inhibitor 65 LY# [003] 65 BiTE 65 vascular disrupting agent 65 PEG SN# 65 5 HT6 receptor 65 rhIL 7 65 histone deacetylase HDAC 65 Nanobody ® 65 Blinatumomab 65 Enzastaurin 65 selective inhibition 65 humanized monoclonal antibody 65 selective modulator 65 MAGE A3 ASCI 65 novel topoisomerase 65 novel peptide 65 RhuDex ® 65 P#X# 65 DXL# 65 protein kinase inhibitor 65 trial evaluating PRX# 65 CCR9 antagonist 65 Nanobody 65 Panzem 65 Tesetaxel 65 BAY #-# 65 sodium glucose cotransporter 65 alpha folate receptor 65 histone deacetylase HDAC inhibitor 65 selective agonist 65 SERMs 65 orally administered inhibitor 65 liposomal formulation 64 investigational pan BCR 64 Sapacitabine 64 ganetespib 64 Vascugel 64 preclinically 64 Virulizin ® 64 Traficet EN 64 ATL# [001] 64 CRLX# 64 Tarvacin 64 Maribavir 64 systemically administered 64 Aplidin 64 PSMA ADC 64 mGluR2 NAM 64 CA4P 64 CCR9 64 ocular formulation 64 intranasal delivery 64 angiogenesis inhibitor 64 CCX# 64 MGd 64 indibulin 64 NeuroTrans TM 64 Cannabinor 64 obatoclax 64 Guanilib 64 Novolimus 64 HuMax EGFr 64 PEGylated 64 CCR5 antagonist 64 TRO# 64 #D#C# 64 chemokine receptor 64 proteasome inhibitors 64 IAP inhibitor 64 PROCHYMAL 64 oxidative stress inducer 64 depsipeptide 64 cilengitide 64 CBLC# 64 Safinamide 64 pathophysiological effects 64 APOPTONE 64 seliciclib 64 Ceflatonin R 64 JAK1 64 Omacetaxine 64 fosbretabulin 64 PKC# 64 cMET 64 effector function 63 cleavable linker 63 cytostatic 63 Mipomersen 63 Tarvacin TM 63 PDE4 inhibitor 63 mGluR2 63 AMD# [003] 63 PORxin TM 63 pharmacodynamic properties 63 INT# [002] 63 potent topoisomerase II 63 CCR2 63 Vicinium TM 63 ProSavin 63 CYC# 63 Seliciclib 63 phase IIa clinical 63 vinca alkaloid 63 YONDELIS 63 Cotara ® 63 selective kinase inhibitor 63 TNF alpha selectively neutralizing 63 Onconase 63 Golimumab 63 radezolid 63 Azedra 63 CR# vcMMAE 63 Kahalalide F 63 potent antiproliferative 63 Pralatrexate 63 CGEN # 63 Marqibo TM 63 AQ4N 63 preclinical efficacy 63 5 HT4 receptor 63 OMP #M# 63 ATL/TV# 63 oral ghrelin agonist 63 novel histone deacetylase 63 HCV protease inhibitors 63 #I TM# 63 partial agonist 63 THR beta agonist 63 radiation sensitizer 63 VA# [002] 63 targeting CD# 63 Lubiprostone 63 JAK2 inhibitor 63 Debio 63 IgG1 antibody 63 Romidepsin 63 delafloxacin 63 PXD# 63 Pertuzumab 63 anti CD3 63 ZFP TF 63 flavopiridol 63 vidofludimus 63 elacytarabine 63 Pazopanib 63 immune modulatory 63 KRN# 63 Ceflatonin 63 OXi# 63 TG# [003] 63 Tanespimycin 63 Soliris eculizumab 63 selective antagonist 63 cobiprostone 63 solithromycin 63 thymalfasin 63 potent suppressor 63 vitro assay 63 PRTX 63 CTAP# Capsules 63 Talabostat 63 teriflunomide 63 OncoVEX 63 VEGF receptor 63 R#/MEM # 63 Lu AA# 62 CIMZIA ™ 62 EZN 62 Fleximer 62 BioNumerik 62 protein tyrosine phosphatase 1B 62 tafamidis 62 oncolytic 62 TriRima 62 p# inhibitor 62 ImmunoVEX HSV2 62 oncolytic virus 62 potently inhibited 62 nanopharmaceutical 62 Azixa 62 evaluating tivozanib 62 Triolex 62 IMC A# 62 Amplimexon 62 Aurora Kinase 62 antisense drug 62 DuraSite 62 oral JAK1 62 recurrent glioblastoma multiforme 62 TNF Tumor Necrosis Factor 62 MTP inhibitor 62 small molecule tyrosine 62 ENMD # 62 Onalta 62 Squalamine 62 Vernakalant 62 sorafenib tablets 62 nucleotide analog 62 antibody MAb 62 VEGF inhibitors 62 INS# [001] 62 Amrubicin 62 Zoraxel 62 BNC# 62 MKC# MKC# PP 62 Elotuzumab 62 peripherally acting 62 A3 adenosine receptor 62 tanespimycin 62 HCV NS5B polymerase 62 antithrombotic 62 VAPRISOL 62 VitiGam 62 Personalized Immunotherapy 62 Janus kinase 62 INCB# [003] 62 FOLOTYN ® 62 Dapagliflozin 62 IAP inhibitors 62 vascular disrupting 62 TLR9 agonist 62 IRX 2 62 Aflibercept 62 SAR# [004] 62 nanoviricide 62 Aviptadil 62 sd rxRNA 62 small molecule defensin 62 peptibody 62 Bicifadine 62 Alfacell proprietary ribonuclease 62 NEUGENE 62 eltrombopag 62 Bavituximab 62 FK# 62 glucagon receptor 62 PNP inhibitor 62 anticancer activity 62 LNPs 62 induces apoptosis 62 Rebif ® 62 Tamibarotene 62 dyskinesia PD LID 62 Tumor Necrosis Factor 62 ziconotide 62 FGFR 62 LEUKINE 62 Oral NKTR 62 ANAVEX #-# [003] 62 potent inhibitor 62 HepDirect prodrug 62 resolvin 62 antitumor 62 epothilones 62 Tasimelteon 62 EP #R 62 HCV protease inhibitor 62 prodrug 62 Zysolin TM 62 PRX# 62 Elagolix 62 mda 7 62 targeted antifolate 62 SRT# [003] 62 Tß4 62 selective adenosine 62 mGluR5 NAM 62 Curaxin 62 anticancer agent 62 OHR/AVR# 62 Pathway Inhibitor 62 virus HCV protease inhibitor 62 receptor inhibitor 62 Arimoclomol 62 favorable pharmacokinetic profile 62 Fc fusion protein 62 vivo validation 61 nucleoside analog 61 generation antisense inhibitor 61 Enzyme Replacement Therapy 61 selective androgen receptor modulator 61 Catena ® 61 CDK inhibitor 61 AAG geldanamycin analog 61 LPA1 receptor 61 humanized monoclonal 61 accumulate preferentially 61 T#I [002] 61 PSN# [002] 61 MEK inhibitor 61 sitaxsentan 61 mTOR inhibitors 61 Atiprimod 61 Sudhir Agrawal D.Phil 61 Akt inhibitor 61 Daclizumab 61 Vidofludimus 61 BAL# [001] 61 Stapled Peptide 61 Valdoxan 61 DDP# 61 Elvitegravir 61 CIMZIA TM 61 OncoGel 61 Phase IIa trial 61 Proxinium TM 61 Lisofylline LSF 61 PI3K/mTOR 61 triphendiol 61 vorinostat 61 Perifosine 61 Hsp# inhibitor 61 synthetic siRNA 61 Excellarate 61 selectively inhibited 61 mu opioid receptor antagonist 61 Phase Ib study 61 immune modulation 61 Bezielle 61 plasma kallikrein inhibitor 61 neurotrophic 61 thalidomide Thalomid 61 PI3K delta 61 anticancer compound 61 torezolid 61 tezampanel 61 Anavex #-# 61 histone deacetylase inhibitors 61 novel oral anticoagulant 61 generation antisense 61 Janus Kinase 61 inhibit EGFR 61 multitargeted 61 CD# antibody [001] 61 chemotherapeutic drug 61 Quinamed 61 PI3K/Akt pathway inhibitor 61 orally dosed 61 ZACTIMA 61 potent anticancer 61 PSN# [001] 61 kidney urologic 61 HyACT 61 tubulin inhibitor 61 Palifosfamide 61 talabostat 61 neuroprotective properties 61 PD LID 61 Synavive 61 Tarceva TM 61 relapsed leukemia 61 pharmacokinetic PK 61 Qutenza TM 61 Icatibant 61 triggers apoptosis programmed 61 therapeutic monoclonal antibodies 61 PrevOnco 61 Radezolid 61 SCH # 61 enzastaurin 61 Beta catenin pathway 61 Fx #A 61 SYN# 61 IMP# 61 CCR1 61 MET amplification 61 Pharmacokinetics PK 61 IMC #B 61 imatinib Gleevec ® 61 RECOTHROM R 61 HTS assay 61 biologic therapeutics 61 JAK3 61 GW# [003] 61 preclinical studies 61 Gleevec resistant 61 MYDICAR ® 61 tramiprosate 61 Lixivaptan 61 polymerase inhibitors 61 potent cytotoxic 61 GLYX 61 microtubule inhibitor 61 riociguat 61 anticoagulant reversing agent 61 GSK# [002] 61 Relivar 61 mTOR kinase 61 SLx 61 ixabepilone 61 CD# expressing 61 pertuzumab 61 oral FTY# 61 Dasatinib 61 AP# [003] 61 Sphingomab 61 MNTX 61 PEGylated interferon 61 GAP #B# 61 antisense inhibition 61 Temsirolimus 61 davunetide intranasal AL 61 immune modulating 61 Bortezomib 61 PEGylated Fab fragment 61 PGL# 61 Degarelix 61 MAb 61 alagebrium 61 tiapamil 61 GV# [001] 61 engineered RAP peptides 61 IL #E 61 alvespimycin 61 ANAVEX #-# [001] 61 HGS ETR1 61 EndoTAG TM -1 61 Viprovex TM 61 midstage clinical 61 LY# [002] 61 hormone LHRH antagonist 61 MT#/MEDI-# 61 JAK#/JAK# 61 Evoltra ® 61 Cethrin 61 CEQ# 61 Angiolix 61 Parkinson disease levodopa induced 61 thrombin receptor 61 intravesical instillation 61 phase IIb trial 61 IMiDs R 61 Factor VEGF 61 TOCOSOL Camptothecin 61 sorafenib Nexavar 61 dextofisopam 61 hypoxia inducible factor 61 forodesine 61 phase IIb study 61 anti leukemic 61 Alemtuzumab 60 JAK inhibitors 60 CG# [003] 60 IGF IR 60 romidepsin 60 TACI Ig 60 RGB # 60 ISIS # 60 Tavocept 60 MEK inhibitors 60 acetonide FA 60 EGS# 60 Curaxin CBLC# 60 Vilazodone 60 imetelstat 60 mecamylamine 60 Plicera 60 HCV protease 60 pegylated 60 TNFa 60 antitumoral 60 TPI ASM8 60 Denufosol 60 Vidaza azacitidine 60 #HT#A 60 liposomal doxorubicin 60 TÎ ² 4 60 delta isoform 60 Cethrin R 60 erlotinib Tarceva ® 60 inhibit metastasis 60 OncoVEX GM CSF 60 VEGF receptor inhibitor 60 iroxanadine 60 Phase 2a clinical 60 Cetrorelix 60 midstage trials 60 OMNARIS HFA 60 pomalidomide 60 phase IIb clinical 60 therapeutic antibody 60 HDAC Inhibitor 60 LEX System 60 Dalbavancin 60 ALN TTR# 60 Elesclomol 60 Aliskiren 60 immunostimulatory 60 Phase #b/#a trial 60 OvaRex R 60 ZOLINZA 60 Galectin 60 humanised monoclonal antibody 60 CXB# 60 endothelin receptor 60 omacetaxine mepesuccinate 60 peptide conjugated 60 Laquinimod 60 reslizumab 60 inhibits VEGF 60 NMDA antagonist 60 Phase III Clinical Trial 60 Fibrillex TM 60 TG# [001] 60 EpCAM 60 Iloperidone 60 pro angiogenic 60 Troxatyl 60 Epidermal Growth Factor Receptor 60 Civacir 60 DOS# 60 Tezampanel 60 NS4A 60 rNAPc2 60 Ambrisentan 60 Cloretazine R 60 ARIKACE 60 relapsed multiple myeloma 60 ganaxolone 60 Preclinical studies suggest 60 anticancer therapy 60 histone deacetylase inhibitor 60 tasocitinib 60 Trastuzumab 60 EndoTAG 60 investigational monoclonal antibody 60 Cytotoxic T 60 Nektar PEGylation technology 60 HSP# inhibitor 60 interleukin IL -# 60 Phase #/#a 60 BRAF inhibitors 60 NV1FGF 60 Harbor BioSciences 60 ALN VSP 60 erythropoietic 60 huN# DM1 60 lorvotuzumab mertansine 60 Deforolimus 60 humanized antibody 60 Microplasmin 60 CD# monoclonal antibody 60 CRx 60 Vaprisol 60 drug zotarolimus 60 trodusquemine 60 CIPN 60 HCD# [002] 60 Vandetanib 60 class mGluR5 inhibitor 60 Locked Nucleic Acid LNA 60 MLN# 60 SGS# 60 Delafloxacin 60 CYT# 60 Phase 2a 60 Homspera TM 60 Solazed TM 60 SAR# [002] 60 sipuleucel T 60 Protein Kinase C 60 HuMax CD# 60 Alocrest 60 Litx 60 Olaparib 60 Ampakine 60 DAVANAT 60 Ophena 60 GLP toxicology studies 60 TRAIL R2 60 immatics 60 compound AEZS 60 Bendavia 60 acyclovir Lauriad R 60 antimitotic 60 Serdaxin 60 ELND# 60 Exherin TM 60 antisense oligonucleotide 60 XmAb ® 60 PDGF receptor 60 demonstrated antitumor activity 60 Darusentan 60 nicotinic alpha 7 60 somatostatin analogue 60 ospemifene 60 CORT # 60 Phase Ib clinical 60 PARP inhibitor 60 Natalizumab 60 IL# PE#QQR 60 CB2 receptor 60 Prednisporin 60 immunotherapeutic agent 60 Resten NG 60 novel immunotherapeutic 60 Imprime PGG 60 prostone 60 Phase #b/#a clinical 60 cetuximab Erbitux ® 60 HDACi 60 antiangiogenic activity 60 Genentech Rituxan 60 tipifarnib 60 phase 2a 60 humanized monoclonal antibodies 60 glioblastoma multiforme GBM 60 VivaGel TM 60 Adentri 60 MT# MEDI 60 methyl D aspartate 60 Aganocide 60 PROSTVAC TM 60 XL# inhibits 60 ThGRF 60 Methylnaltrexone 60 Prodarsan ® 60 bispecific 60 aurora kinase 60 peptidomimetic 60 Trofex 60 talactoferrin 60 oral Janus kinase 60 small molecule activators 60 methionine aminopeptidase 60 BEMA TM Fentanyl 60 REG2 60 OncoVex 60 Logical Therapeutics 60 vinca alkaloids 60 prucalopride 60 DermaVir Patch 60 pDCs 60 NP2 60 Panzem R NCD 60 thrombopoietin 60 Angiocept 60 rxRNA 60 HGS ETR2 60 OMP #R# 60 epigenetic therapies 60 Rasagiline 60 CB2 selective receptor agonist 60 DepoVax 60 omega interferon 60 Annamycin 60 highly selective inhibitor 60 oral antiviral 60 defensin mimetic antibiotic 60 HuLuc# 59 synthetic retinoid 59 Solulin 59 oral proteasome inhibitor 59 DermaVir 59 vWF 59 acadesine 59 MGCD# [001] 59 Nanobodies 59 S/GSK# 59 Desmoteplase 59 afamelanotide 59 Ocrelizumab 59 prodrugs 59 Cariprazine 59 immunomodulatory 59 Multimeric 59 lenalidomide Revlimid R 59 retapamulin 59 Orally administered 59 YONDELIS R 59 Phase IIb clinical trials 59 HepaLife PICM 59 fibrotic disease 59 Davunetide 59 TKB# 59 Monoclonal antibody 59 neratinib 59 PDX pralatrexate 59 Alzhemed TM 59 Epratuzumab 59 mGluR5 negative 59 MDV# 59 bioactive lipids 59 RAV# 59 oral rivaroxaban 59 Nexavar ® 59 inverse agonist 59 preclinical models 59 FluCide 59 Teriflunomide 59 KNS # 59 deacetylase inhibitors 59 Vorinostat 59 Phase III Pivotal 59 selective inverse agonist 59 stable nucleic acid 59 Anticalins ® 59 protein kinase inhibitors 59 Pradefovir 59 antibody MT# 59 beta 1a 59 Milatuzumab 59 SGLT2 59 Crizotinib 59 CobaCyte 59 OX1 59 diagnostic biomarker 59 Anticalins R 59 AMPAKINE 59 ON #.Na 59 ACZ# 59 polysaccharide polymer 59 humanized anti 59 CRMD# 59 bardoxolone methyl 59 virotherapy 59 PRT# 59 thetreatment 59 Aptivus ® 59 Belerofon 59 OXIGON TM 59 NASDAQ SNTA 59 KSP inhibitor 59 Cotara R 59 c Raf kinase 59 ELND-#/AZD-# 59 gefitinib Iressa 59 NexACT 59 LEP ETU 59 AKT inhibitor 59 elvucitabine 59 Randomized Phase 59 oral renin inhibitor 59 formerly LymphoStat B 59 recombinant adeno associated 59 NTDDS 59 adipiplon 59 Factor Xa inhibitor 59 diabetic neuropathic pain 59 IPL# 59 peptidic compound 59 Lamotrigine 59 #ME# 59 INGN 59 Panzem R 59 cytoprotective 59 Velcade bortezomib 59 cortisol synthesis 59 anti EGFR antibody 59 HuCNS SC ® 59 sd rxRNA compounds 59 HDL Selective Delipidation 59 NEUGENE R 59 Silodosin 59 Phase 1a clinical 59 alefacept 59 PLX MS 59 PS# [001] 59 c MET 59 Cethromycin 59 antibody fragment 59 HuMax CD4 59 ALGRX 59 Anticalin ® 59 Insegia 59 RAS MAPK pathway 59 Angiochem 59 dose escalation Phase 59 Gefitinib 59 histone deacetylase HDAC inhibitors 59 pseudobulbar affect PBA 59 PI3K inhibitor 59 milatuzumab 59 mGluR2 positive 59 Allovectin 7 59 Zingo TM 59 LHRH antagonists 59 TELINTRA 59 multicenter Phase II 59 GRN#L 59 Glypromate 59 Azedra TM 59 CDDO Im 59 anti angiogenic agent 59 Omacetaxine mepesuccinate 59 constipation predominant irritable bowel 59 pharmacodynamic PD 59 immunotoxin 59 Zalypsis 59 SERCA2a 59 relapsing remitting multiple sclerosis 59 topically administered 59 REG1 59 metabotropic glutamate receptors 59 5 HT2A receptor 59 decitabine 59 bosutinib 59 HER2 antibody 59 AEGR 59 non nucleoside HCV 59 Virulizin R 59 pharmacological chaperone 59 IMiDs ® 59 administered subcutaneously 59 BN# [002] 59 insulin sensitizers 59 Milnacipran 59 MORAb 59 hypoxia activated prodrug 59 rALLy clinical trial 59 TLR7 59 novel immunomodulatory 59 Tolvaptan 59 Cx# [002] 59 PCK# 59 PORxin TM platforms 59 brivaracetam 59 xenograft models 59 HGS# 59 exon skipping 59 myelofibrosis polycythemia vera 59 masitinib 59 sunitinib malate 59 CB1 antagonists 59 Hsp# inhibition 59 Inhalation Solution 59 RSD# 59 TNFα 59 renin inhibitor 59 Lorianne Masuoka MD 59 cancer immunotherapies 59 Alzheimer disease cognitive impairment 59 Arcalyst 59 lapatinib Tykerb 59 myeloproliferative diseases 59 PLX cells 59 DiLA2 59 RoACTEMRA 59 nanoviricides 59 biased ligand 59 synthetic peptide 59 TMC# [002] 59 lipid nanoparticle 59 MGN# 59 RhuDex 59 intranasal formulation 59 miRview ™ squamous 59 CERE 59 GGF2 59 EndoTAG TM 59 adrenergic regulation 59 trastuzumab DM1 T DM1 59 dexpramipexole 59 tyrosine kinase inhibitor 59 metastatic colorectal 59 HDAC EGFR 59 Tarmogen 59 PDE# inhibitors 59 Chemokine Therapeutics 59 TLK# 59 atrasentan 59 bevacizumab Avastin ® 59 antiangiogenic agent 59 Zolinza 59 Enkephalin 59 Cleviprex TM clevidipine 59 refractory gout 59 lucinactant 59 PI3 kinase inhibitors 59 Interferon beta 59 pain palliation 59 Tocilizumab 59 GRNOPC1 contains 59 SPC# [001] 59 AEZS 59 Clavis Pharma 59 alemtuzumab Campath 59 UPLYSO 58 NGX# 58 glycosylated 58 mitogen activated ERK kinase 58 Apo2L 58 Spiegelmers R 58 Myocet 58 oral Factor Xa 58 siRNA therapeutic 58 PDE4 inhibitors 58 Vascular Endothelial Growth 58 Preclinical studies 58 CD# CEA 58 EGFr 58 BCR ABL inhibitors 58 BZL# 58 adenoviral 58 Aurexis 58 hedgehog pathway 58 Phase 2a trial 58 REMUNE R 58 favorable pharmacokinetic 58 Aclidinium 58 HepDirect technology 58 Pimavanserin 58 anti proliferative 58 PROMACTA 58 drug conjugate 58 C5aR 58 superficial bladder cancer 58 glucokinase activator 58 MVA BN 58 bortezomib Velcade ® 58 receptor agonists 58 plasma pharmacokinetics 58 ELACYT 58 HER2/neu 58 metastatic neuroendocrine tumors 58 AeroLEF TM 58 cetuximab Erbitux R 58 Immunotherapeutic 58 TREANDA 58 mapatumumab 58 mTOR inhibition 58 Solorel TM 58 TLR8 58 HSP# inhibitors 58 replicon 58 CRD5 58 calcineurin inhibitors 58 zotarolimus 58 GRNVAC1 58 ONCONASE R 58 NOD mouse 58 selective orally bioavailable 58 ADP receptor antagonist 58 HCV polymerase inhibitor 58 AngioChem 58 Fibrillex 58 NP2 Enkephalin 58 AVN# [001] 58 BRIM2 58 pharmacokinetic PK study 58 monoclonal antibodies MAbs 58 signal transduction inhibitor 58 macrolide antibiotics 58 ulimorelin 58 PLK1 SNALP 58 randomized Phase IIb 58 Mirapexin 58 S1P 58 LHRH antagonist 58 TRX1 58 Nanobodies ® 58 Campath ® 58 HuCAL antibodies 58 Phase 1b trial 58 PRIALT 58 NEUGENE antisense 58 aripiprazole Abilify 58 FLT3 58 Fibroblast Growth Factor Receptor 58 Aptamer 58 optimized siRNA 58 darapladib 58 ZYBRESTAT